Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: Cancer. 2015 Jun 19;121(19):3491–3498. doi: 10.1002/cncr.29507

Table I.

Major and minor clinical criteria used to determine eligibility in the ACOSOG Z4033* study.

Major Criteria Total**
(N=51)

  1. FEV1 ≤ 50% predicted 28 (54.9%)
  2. DLCO ≤ 50% predicted 33 (64.7%)

Minor Criteria

  1. Age ≥75 30 (58.8%)
  2. FEV1 51–60% predicted 7 (13.7%)
  3. DLCO 51–60% predicted 9 (17.6%)
  4. Pulmonary hypertension (defined as a pulmonary artery systolic pressure greater than 40mmHg) as estimated by echocardiography or right heart catheterization 1 (2.0%)
  5. Poor left ventricular function (defined as an ejection fraction of 40% or less) 6 (11.8%)
  6. Resting or Exercise Arterial pO2 ≤ 55 mm Hg or SpO2 ≤ 88% 1 (2.0%)
  7. pCO2 > 45 mm Hg 0 (0%)
  8. Modified Medical Research Council (MMRC) Dyspnea Scale ≥ 3 12 (23.5%)

MMRC=modified medical research council scale.

*

Eligible patients must have met either 1 Major or 2 Minor Criteria

**

Patients may have multiple criteria